LONDON, England—Two-year results from the CLASP IID randomized trial and registry confirm the early benefits of transcatheter edge-to-edge repair (TEER) with the Pascal system (Edwards Lifesciences) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback